Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy

Impact of Bivalent BA.4/5 BNT162b2 COVID-19 Vaccine on Acute Symptoms, Quality of Life, Work Productivity and Activity Levels among Symptomatic US Adults Testing Positive for SARS-CoV-2 at a National Retail Pharmacy

Evidence on the impact of COVID-19 vaccination on symptoms, Health-Related Quality of Life (HRQoL) and Work Productivity and Activity Impairment (WPAI) is scarce. We analyzed associations between bivalent BA.4/5 BNT162b2 (BNT162b2) and these patient-reported outcomes (PROs). Symptomatic US adults te...

Full description

Bibliographic Details
Main Authors: Manuela Di Fusco, Xiaowu Sun, Laura Anatale-Tardiff, Alon Yehoshua, Henriette Coetzer, Mary B. Alvarez, Kristen E. Allen, Thomas M. Porter, Laura Puzniak, Santiago M. C. Lopez, Joseph C. Cappelleri
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Vaccines
Subjects:
SARS-CoV-2
BA.4/5 BNT162b2
bivalent
COVID-19
COVID-19 symptoms
HRQoL
Online Access:https://www.mdpi.com/2076-393X/11/11/1669

Similar Items

Similar Items